Slide Decks on Schizophrenia
Schizophrenia is characterized by distortions in thinking, perception, emotions, language, sense of self and behavior. Worldwide, schizophrenia is associated with considerable disability and may affect educational and occupational performance.
Get an introduction to schizophrenia or dive into details on the subject by going through our slide decks. In each slide deck, you will encounter an introductory overview of the subject and gain insights into fundamental concepts of schizophrenia. Our slide decks encompass a range of topics, including the broad range of symptoms in schizophrenia, the emotional and practical burdens of schizophrenia on families, and the adherence to antipsychotic therapy in schizophrenia.
You can view, and download all our slide decks for free.
Neurobiology and Aetiology
This slide deck presents an introduction to neuroanatomy, the key components of neurosynaptic transmission, neurotransmitters and the pathophysiology of schizophrenia. Go to the slide deck.
Definitions and Diagnosis
People with schizophrenia commonly experience hallucinations and delusions. In this slide deck, basic concepts and definitions related to schizophrenia are explored. Go to the slide deck.
This slide deck covers the progression of schizophrenia and functional decline. You will gain insight into treatment principles, the impact of adverse events on patients and the importance of early intervention for patients with schizophrenia. Go to the slide deck.
Epidemiology and Burden
This slide deck explores the epidemiology and burden of schizophrenia and includes illustrations of the economic burden of the illness. Go to the slide deck.
Course, Natural History and Prognosis
Schizophrenia is a progressive and recurring disease characterized by multiple psychotic relapses. This slide deck covers the course, natural history and prognosis of schizophrenia. Go to the slide deck.
Psychiatric and somatic comorbidities, elevated mortality and patient quality of life are discussed in this slide deck, which also includes slides discussing the key features of the illness. Go to the slide deck.
Selected Articles on Schizophrenia
Explore articles on schizophrenia, a global concern affecting over 20 million individuals, leading to substantial psychosocial impairments. Discover insights on biomarkers for prevention and treatment, the hypothesis of pathological aging in schizophrenia, and the enhanced quality of life for first episode psychosis patients through evidence-based psychosocial and pharmacological interventions.
- Novel and Emerging Pharmacologic Treatments for SchizophreniaThis article reviews novel pharmacologic agents, summarizing their proposed mechanism of action (MOA) and currently available clinical data, putting these developments into the context of treatment gaps, clinical trial methodology, and required further real-world evaluation.
- A roadmap to bring neuroimaging biomarkers for schizophrenia to the clinicBased on a body of literature on striatal function and treatment response, multiple neuroimaging prognostic biomarkers have been developed, of which two seem to have the most data for internal and external validation. This is a promising development towards the goal of developing biomarkers that inform individual treatment choices in schizophrenia.
- Preventing Suicide – A Global ImperativeThis article addresses the global public health challenge of suicide, and explores important initiatives to improve understanding the complex causes of suicide and enhance prevention efforts.
Watch the Videos on Schizophrenia
Schizophrenia is treatable. Treatment with medicines and psychosocial support is effective. When selecting treatments for schizophrenia, physicians have to consider many variables, including the patient’s health and lifestyle, co-prescribed medications and previously experienced adverse events. Access our videos where experts explain complex topics in a clear and accessible manner.
In this video Professor Christoph Correll discusses the challenges we have with the available schizophrenia treatments today. He also touches upon what clinicians should keep in mind when considering the emerging treatment options for their patients living with schizophrenia.
Professor Christoph U. Correll, Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany and also Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA.
Download Illustrations & Figures on Schizophrenia
Access images for use on Schizophrenia, including illustrations encompassing various aspects such as an overview of the global impact of schizophrenia, stages of biomarker discovery from target identification to clinical benefit verification, and exemplars of clinically valuable biomarkers in medical practice.
3D Brain Atlas
- The positive symptoms of schizophrenia are thought to be caused by an excess of dopamine within the pathway of the brain that projects from the ventral tegmental area in the brain stem to the nucleus accumbens in the ventral striatum.[Owen et al. (2016),Stahl, S. M. (2013)]
- Schizophrenia’s cognitive and certain negative symptoms may result from reduced dopamine activity in mesocortical projections to the dorsolateral prefrontal cortex, while affective and other negative symptoms may stem from deficits in projections to the ventromedial prefrontal cortex.[Stahl, S. M. (2013)]